Beyond Target Occupancy in Triple-Negative Breast Cancer: A Medicinal Chemistry Perspective on Modality-Guided Design...

Area of Science:

• Oncology
• Medicinal Chemistry
• Cancer Biology

Background:

• Triple-negative breast cancer (TNBC) poses significant treatment challenges, with conventional therapies rarely achieving durable responses.
• The difficulty in treating TNBC stems from its adaptive network biology, which is not adequately addressed by reversible, single-target interventions.
• Existing treatment strategies often fail to bridge the gap between TNBC's complex biology and the limited scope of current therapeutic interventions.

Purpose of the Study:

• To reframe the medicinal chemistry challenge in TNBC treatment, focusing on matching chemical modalities to biological vulnerabilities.
• To explore how understanding TNBC's adaptive network biology can inform the design of more effective therapeutic strategies.
• To highlight the importance of chemical modality selection in achieving durable control over TNBC's complex biological networks.

Main Methods:

• Discussion of TNBC vulnerabilities including metabolic coupling, epigenetic scaffold dependence, immune-stromal exclusion, and DNA damage response plasticity.
• Exploration of targeted protein degradation, molecular glues, covalent inhibition, rational polypharmacology, and prodrug design as potential intervention modalities.
• Analysis of key factors influencing therapeutic success, such as ternary-complex productivity, linker topology, and isoform selectivity.

Main Results:

• Specific TNBC vulnerabilities suggest the utility of diverse chemical modalities beyond traditional occupancy-driven inhibition.
• Factors like ternary-complex productivity, linker topology, and isoform selectivity are critical for durable therapeutic effects.
• The choice of chemical modality is crucial for effectively intervening in TNBC's adaptive network biology.

Conclusions:

• Biological vulnerability in TNBC dictates the design of therapeutic interventions.
• Chemical modality selection is key to defining the logic of intervention for TNBC.
• Achieving durable network control, rather than just target potency, defines successful TNBC treatment strategies.